Use of mild cognitive impairment and prodromal AD/MCI due to AD in clinical care: a European survey.

ABSTRACT:

Introduction

The diagnosis of mild cognitive impairment (MCI) refers to cognitive impairment not meeting dementia criteria. A survey among members of the American Association of Neurology (AAN) showed that MCI was considered a useful diagnosis. Recently, research criteria have been proposed for the diagnosis of Alzheimer's disease (AD) in MCI based on AD biomarkers (prodromal AD/MCI due to AD). The aim of this study was to investigate the attitudes of clinicians in Europe on the clinical utility of MCI and prodromal AD/MCI due to AD criteria. We also investigated whether the prodromal AD/MCI due to AD criteria impacted management of MCI patients.

Methods

An online survey was performed in 2015 among 102 members of the European Academy of Neurology (EAN) and the European Alzhe

SUBMITTER: Bertens D 

PROVIDER: S-EPMC6706888 | biostudies-literature | 2019 Aug

REPOSITORIES: biostudies-literature